[Zacks | Our Research. Your Success.] Last Chance to Beat Wall Street to This Ticker {NAME}, Did you miss my earlier email? I want to give you one more chance to ride the historic growth trajectory of legal marijuana from $24.6 billion in 2020 as it explodes to an expected $97.35 billion by 2026. This estimate might be conservative. The Senate is on the brink of legalizing marijuana on the federal level after the Senate Majority Leader introduced draft legislation. Medicinal marijuana is already legal in 37 states with 18 doing the same for recreational use. It’s already legal in Canada and Mexico's Supreme Court made private and recreational use legal in June of this year, though specific details of that legislation are still a bit unclear. As a result of these developments, companies within the space are about to take off. Additionally, new ones will emerge and current stocks could skyrocket. The trend is overwhelming. Zacks' Marijuana Innovators portfolio recently closed a +147.0% trade in Innovative Industrial Properties. We're currently riding gains as high as +93.03% and +133.33%.¹ We bought those companies near their lows and, in my view, they still have a long way to run which can be very good news for you. Even better, I'm lining up strong U.S.-listed companies that could rival or surpass those gains. I should mention that our approach avoids the dicey penny stocks, targeting the few growers, pharmaceuticals, financial firms, suppliers - both established and start-ups - that are the true innovators and offer the most reliable potential for double and triple-digit gains. Tuesday morning at 11:05 am ET, I'll post a big marijuana stock with a much bigger upside. This company is definitely one to keep an eye on. It’s a cannabis firm that provides innovative software to North American companies in the marijuana industry so they can better ensure inventory management and regulatory compliance. Through a growing portfolio of marijuana-focused tech companies, the organization I’ve picked has enterprise solutions that will help the industry, as a whole, track and better understand everything from seed to sale. Its price could skyrocket in the coming weeks and months. Don't miss this chance to get in early. It couldn't be easier to gain 30-day access to the buys, sells, and commentary of our Marijuana Innovators portfolio. Your total cost? Only $1. But please remember that we can't allow too many investors to jump on our selected stocks. The portfolio has been closed since June. Re-opened briefly, it closes to entry again just hours from now - midnight tonight Sunday, September 5. I look forward to sharing this generational investment opportunity with you at the ideal time. People are being vaccinated. The unleashing of pent-up economic demand is primed to electrify the overall market. And a new industry is entering its phase of explosive growth. Bonus Report: You may also download our Special Report, 5G: Top Stocks for the $12 Trillion Data Revolution. Experts have said 5G could spark a new technological renaissance. Trillions of dollars will be spent building 5G devices and infrastructure creating an enormous financial opportunity. This report reveals 3 companies leading the charge. Each of these stocks could generate huge profits for early investors. [▶ See Stocks Now]( All the Best, [Benjamin Rains - signature]
Ben Rains
Editor of Marijuana Innovators ¹ As of 8/30/2021. The results listed above are not (or may not be) representative of the performance of all selections made by Zacks Investment Research's newsletter editors and may represent the partial close of a position. This free resource is being sent by [Zacks.com](. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms of Service". [( Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research is not a licensed securities dealer, broker or US investment adviser or investment bank. The Zacks #1 Rank Performance covers the period beginning on January 1, 1988 through June 28, 2021. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank #1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit [( for information about the performance numbers displayed above. Zacks Emails
If you would prefer to not receive future profit-producing emails from [Zacks.com]( the primary purpose of which is the commercial advertisement or promotion of a commercial product or service, then please [click here]( and confirm your request. If you have trouble with the unsubscribe link, please email support@zacks.com. Zacks Investment Research
10 S. Riverside Plaza, Suite 1600
Chicago, IL 60606